Top-News

BeOne Medicines Aktie (ADR) News

Aktie
WKN:  A1437N ISIN:  US07725L1026 US-Symbol:  ONC Branche:  Biotechnologie Land:  Schweiz
316,86 $
-14,54 $
-4,39%
272,14 € 19:08:51 Uhr
Depot/Watchlist
Marktkapitalisierung *
34,37 Mrd. €
Streubesitz
46,59%
KGV
-30,43
Faktor
0.0769231
Originalaktie
CH1391448177

BeOne Medicines Aktie (ADR) News

23.05.25 - PR Newswire
New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs
New Data and Deal Flow Signal a Turning Point for Precision-​Driven Cancer Biotechs PR Newswire
23.05.25 - PR Newswire
Oncolytics Biotech® to Present New Clinical Trial Data at ASCO Showing Pelareorep's Unique Immune Activation Capabilities
Oncolytics Biotech® to Present New Clinical Trial Data at ASCO Showing Pelareorep's Unique Immune Activation Capabilities PR Newswire
14.05.25 - PR Newswire
Oncolytics Biotech® Reports First Quarter Financial Results and Highlights Clinical Momentum
Oncolytics Biotech® Reports First Quarter Financial Results and Highlights Clinical Momentum PR Newswire
06.05.25 - PR Newswire
Oncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights
Oncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights PR Newswire
01.05.25 - PR Newswire
New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty
New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty PR Newswire
01.05.25 - PR Newswire
New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty
New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty PR Newswire
24.04.25 - PR Newswire
Oncolytics Biotech® to Showcase New Pancreatic Cancer Data at ASCO Highlighting Pelareorep's Tumor-Fighting Mechanism of Action
Oncolytics Biotech® to Showcase New Pancreatic Cancer Data at ASCO Highlighting Pelareorep's Tumor-​Fighting Mechanism of Action PR Newswire
14.04.25 - PR Newswire
With Young Adult Cancer on the Rise, New Therapies Spark Investor Buzz
With Young Adult Cancer on the Rise, New Therapies Spark Investor Buzz PR Newswire
14.04.25 - PR Newswire
With Young Adult Cancer on the Rise, New Therapies Spark Investor Buzz
With Young Adult Cancer on the Rise, New Therapies Spark Investor Buzz PR Newswire
10.04.25 - PR Newswire
Oncolytics Biotech® Funds Pelareorep's Ongoing Clinical Development with a Share Purchase Agreement in Partnership with Alumni Capital
Oncolytics Biotech® Funds Pelareorep's Ongoing Clinical Development with a Share Purchase Agreement in Partnership with Alumni Capital PR Newswire
10.04.25 - PR Newswire
Oncolytics Biotech® and Pelareorep Discussed During Recent H.C. Wainwright Key Opinion Leader Event on Oncolytic Immunotherapies in Breast and Pancreatic Cancers
Oncolytics Biotech® and Pelareorep Discussed During Recent H.C. Wainwright Key Opinion Leader Event on Oncolytic Immunotherapies in Breast and Pancreatic Cancers PR ...
08.03.25 - PR Newswire
Why the Global Cancer Market Could Surpass $900 Billion--And the Stocks Leading the Charge
Why the Global Cancer Market Could Surpass $900 Billion--And the Stocks Leading the Charge PR Newswire
07.03.25 - PR Newswire
Oncolytics Biotech® Reports Highlights and Financial Results for Q4 and Year-End 2024
Oncolytics Biotech® Reports Highlights and Financial Results for Q4 and Year-End 2024 PR Newswire
27.02.25 - PR Newswire
Oncology Breakthroughs: How Cancer Research Is Advancing in 2025
Oncology Breakthroughs: How Cancer Research Is Advancing in 2025 PR Newswire
27.02.25 - PR Newswire
Oncology Breakthroughs: How Cancer Research Is Advancing in 2025
Oncology Breakthroughs: How Cancer Research Is Advancing in 2025 PR Newswire
25.02.25 - PR Newswire
Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Recent Operational Highlights
Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Recent Operational Highlights PR Newswire
19.02.25 - PR Newswire
Investors Eye Biotech Sector as Cancer Therapy Market Surges
Investors Eye Biotech Sector as Cancer Therapy Market Surges PR Newswire
19.02.25 - PR Newswire
Oncolytics Biotech® Advances Key Pancreatic and Anal Cancer Trials, Strengthening Pipeline in 2025
Oncolytics Biotech® Advances Key Pancreatic and Anal Cancer Trials, Strengthening Pipeline in 2025 PR Newswire
18.02.25 - PR Newswire
Oncolytics Biotech® Strengthens Its Pipeline in 2025 with Key Pancreatic and Anal Cancer Advances in Addition to Metastatic Breast Cancer
Oncolytics Biotech® Strengthens Its Pipeline in 2025 with Key Pancreatic and Anal Cancer Advances in Addition to Metastatic Breast Cancer PR Newswire
14.02.25 - PR Newswire
Oncolytics Biotech® Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
Oncolytics Biotech® Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency PR Newswire

Newssuche

Videos

newspaper
10:20 Uhr +2,17%
Technical Trading: Gold Zukauf Chance
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »